BDBM323230 N-[(R)-2-[3-(2,5-difluorophenyl)-3-pentylazetidin-1-yl]-1-(4-methoxybenzyl)-2-oxoethyl]-3-(1H-imidazol-4-yl)propionamide::US9630949, 60

SMILES CCCCCC1(c2cc(F)ccc2F)CN(C(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)CCc2c[nH]cn2)C1

InChI Key InChIKey=BHVLYVMHJGVLON-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 323230   

TargetMelanocortin receptor 4(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323230BDBM323230(N-[(R)-2-[3-(2,5-difluorophenyl)-3-pentylazetidin-...)
Affinity DataEC50:  100nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323230BDBM323230(N-[(R)-2-[3-(2,5-difluorophenyl)-3-pentylazetidin-...)
Affinity DataEC50:  120nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent